Home Pilots Home allergy testing company Nectar secures $16.5M in funding Pilots Home allergy testing company Nectar secures $16.5M in funding By - December 20, 2022 26 0 Facebook Twitter Pinterest WhatsApp The investment will support the company’s growth nationwide, fund clinical trials and open a physical location. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Virtual-care company Firefly Health partners with Oshi Health for digital digestive care Pilots - March 15, 2022 0 Care enablement company Fabric acquires Walmart’s MeMD Pilots - June 28, 2024 0 Highmark Health, Google Cloud, League partner to build ‘digital front door’ Pilots - November 18, 2022 0 Hims & Hers stock climbs after revenue growth in 2022 Pilots - February 28, 2023 0 Ensuring digital health solutions help, not harm Pilots - February 16, 2023 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3